Ann: Quarterly Activities and Cashflow Report, page-6

What annoys me (apart from the distressed share price) is the forward program Next Steps / Figure 5 with no dates / timeline. Totally useless program representation if it does not give shareholders any measure of when we can expect to see results / output of work tasks just "met test work to commence in July". I suspect they will top up some funds via a placement to sophs at a terrible discount most likely without the ASROBs because those are looking very shaky. Hard to feel confident in the way forward when there is no accountability in a forward program to hold management to. Still holding on a glimmer of hope but despair is starting to set in.